Literature DB >> 20347874

The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice.

Willemijn A van Dop1, Stefano Marengo, Anje A te Velde, Elisa Ciraolo, Irene Franco, Fiebo J ten Kate, Guy E Boeckxstaens, James C Hardwick, Daan W Hommes, Emilio Hirsch, Gijs R van den Brink.   

Abstract

Phosphatidylinositol-3-kinase gamma (PI3Kgamma) is the major PI3K that is activated in response to chemoattractants. It is responsible for the migration of leukocytes from the bloodstream to sites of injury or infection. Constant migration of new leukocytes to the intestinal mucosa may be an important factor in maintenance of inflammation and tissue damage in inflammatory bowel disease (IBD). Reducing this influx, for example by inhibition of PI3Kgamma, might therefore be a potential goal for therapy. Here we investigated the role of PI3Kgamma in the migration of leukocytes to sites of intestinal inflammation. We induced colitis in mice with a point mutation that inactivates PI3Kgamma enzymatic activity ('kinase-dead') by oral administration of dextran sodium sulphate (DSS). Mice were treated with 1.5% DSS for 1 week and effects on cytokine production, leukocyte recruitment and disease severity were examined. Both clinical and histological parameters showed that the severity of colitis was significantly reduced in PI3Kgamma-kinase-dead mice compared to controls. Although mutant mice had a less severe colitis than controls they produced significantly more pro-inflammatory Th1 cytokines such as Il-12, Tnfalpha and Ifngamma and more Il-10. PI3Kgamma mutant mice showed increased numbers of resident macrophages and T cells in the colonic lamina propria in an unstressed condition but failed to recruit new leukocytes to the mucosa upon treatment with DSS despite the increased cytokine levels. These results suggest that PI3Kgamma plays a critical role in lamina propria leukocyte trafficking and that loss of PI3Kgamma-activity ameliorates DSS-induced colitis in mice. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347874     DOI: 10.1016/j.imlet.2010.03.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  13 in total

1.  PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Authors:  Rong Jin; Adam Y Xiao; Jarvis Li; Min Wang; Guohong Li
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

2.  Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.

Authors:  Susan O'Brien; Manish Patel; Brad S Kahl; Steven M Horwitz; Francine M Foss; Pierluigi Porcu; Jeffrey Jones; Jan Burger; Nitin Jain; Kerstin Allen; Kerrie Faia; Mark Douglas; Howard M Stern; Jennifer Sweeney; Patrick Kelly; Virginia Kelly; Ian Flinn
Journal:  Am J Hematol       Date:  2018-10-20       Impact factor: 10.047

3.  Tissue factor-dependent chemokine production aggravates experimental colitis.

Authors:  Karla C S Queiroz; Cornelis Van 't Veer; Yascha Van Den Berg; Janwillem Duitman; Henri H Versteeg; Hella L Aberson; Angelique P Groot; Marleen I Verstege; Joris J T H Roelofs; Anje A Te Velde; C Arnold Spek
Journal:  Mol Med       Date:  2011-06-22       Impact factor: 6.354

4.  Phosphoinositide 3-Kinase Gamma Contributes to Neuroinflammation in a Rat Model of Surgical Brain Injury.

Authors:  Lei Huang; Prativa Sherchan; Yuechun Wang; Cesar Reis; Richard L Applegate; Jiping Tang; John H Zhang
Journal:  J Neurosci       Date:  2015-07-22       Impact factor: 6.167

5.  Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells.

Authors:  R C Dutra; M Cola; D F P Leite; A F Bento; R F Claudino; A F Z Nascimento; P C Leal; J B Calixto
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

6.  The role of phosphoinositide 3-kinase signaling in intestinal inflammation.

Authors:  Catherine M Cahill; Jack T Rogers; W Allan Walker
Journal:  J Signal Transduct       Date:  2012-04-09

7.  New perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation.

Authors:  Mary E Morgan; Bin Zheng; Pim J Koelink; Hendrick J G van de Kant; Lizette C J M Haazen; Manon van Roest; Johan Garssen; Gert Folkerts; Aletta D Kraneveld
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

8.  IL-17A signaling in colonic epithelial cells inhibits pro-inflammatory cytokine production by enhancing the activity of ERK and PI3K.

Authors:  Xiaoqin Guo; Xingwei Jiang; Yan Xiao; Tingting Zhou; Yueling Guo; Renxi Wang; Zhi Zhao; He Xiao; Chunmei Hou; Lingyun Ma; Yanhua Lin; Xiaoling Lang; Jiannan Feng; Guojiang Chen; Beifen Shen; Gencheng Han; Yan Li
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

9.  PI3Kγ kinase activity is required for optimal T-cell activation and differentiation.

Authors:  Nadia Ladygina; Sridevi Gottipati; Karen Ngo; Glenda Castro; Jing-Ying Ma; Homayon Banie; Tadimeti S Rao; Wai-Ping Fung-Leung
Journal:  Eur J Immunol       Date:  2013-10-09       Impact factor: 5.532

10.  Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.

Authors:  Natalia F Smirnova; Stéphanie Gayral; Christophe Pedros; Gervaise Loirand; Nathalie Vaillant; Nicole Malet; Sahar Kassem; Denis Calise; Dominique Goudounèche; Matthias P Wymann; Emilio Hirsch; Alain-Pierre Gadeau; Laurent O Martinez; Abdelhadi Saoudi; Muriel Laffargue
Journal:  J Exp Med       Date:  2014-07-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.